Physician profile
Robert N Severinac
NPI 1033120969
$937.90
in general payments reported to CMS, 2019-2025
11 companies · $487 in 2025
The $487 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $14.06 · 2022: $249 · 2023: $153 · 2024: $34.50 · 2025: $487.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $334 · Travel and Lodging: $253 · Gift: $87.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $334.43 |
| Travel and Lodging | $252.98 |
| Gift | $87.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Motiva USA, LLC | $486.84 | 2025 | |
| Mentor Worldwide LLC | $171.54 | 2022-2023 | Mentor Memorygel Resterilizable Gel Sizer |
| Kowa Pharmaceuticals America, INC. | $64.60 | 2022-2023 | Seglentis |
| Abbvie INC. | $37.37 | 2023 | Natrelle Saline-Filled Breast Implants |
| Revance Therapeutics, INC. | $34.50 | 2024 | Daxxify |
| Medtronic, INC. | $32.01 | 2022 | |
| Sientra, INC. | $28.88 | 2022 | |
| Ethicon US, LLC | $26.39 | 2021-2022 | |
| Allergan, INC. | $21.98 | 2022 | |
| Galderma Laboratories, L.P. | $17.99 | 2022 | |
| Kci USA, INC. | $15.80 | 2023 | V.A.C. Veraflo Cleanse Choice, Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Severinac listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.